NCT07083817View on ClinicalTrials.gov

Mass Balance Study of [14C]Xeruborbactam (QPX7728) in Healthy Adult Male Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

8

Participants

Timeline

Start Date

August 13, 2025

Primary Completion Date

August 27, 2025

Study Completion Date

August 27, 2025

Conditions

ADME

Interventions

DRUG

[14C]Xeruborbactam

Carbon Radiolabeled Xeruborbactam

Trial Locations (1)

NG11 6JS

Quotient Sciences, Nottingham

All Listed Sponsors

collaborator

Shionogi Inc.

INDUSTRY

lead

Qpex Biopharma, Inc.

INDUSTRY